Drug companies received the fewest FDA inspections in Utah during Q1

Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA
Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA
0Comments

In early 2026, the FDA inspected one drugs company in Utah during the first quarter, according to the U.S. Food and Drug Administration (FDA).

This represented the smallest share of inspections by company type conducted by the FDA in Utah, accounting for 5% of all inspections in that period.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

FDA Inspections in Utah During Q1
Project Area No Action Indicated Voluntary Action Indicated Official Action Indicated
Bioresearch Monitoring 1
Blood and Blood Products 1
Colors and Cosmetics Technology 2
Food Composition, Standards, Labeling and Econ 8 4
Foodborne Biological Hazards 10 3

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

John Curtis, U.S. Senator from Utah

Senator John Curtis hosts small business and innovation expo in Utah

Senator John Curtis hosted a small business expo at Davis Technical College highlighting entrepreneurship across Utah. The event brought together leaders from government agencies and local organizations while discussing policy support for innovation.

John Curtis, U.S. Senator from Utah

Curtis discusses Utah’s nuclear energy future and calls for state empowerment in federal policy

Senator John Curtis spoke at a Senate committee hearing about empowering states like Utah in shaping federal nuclear policy. He pressed Nuclear Regulatory Commission leaders about streamlining regulations and supporting small municipal applicants interested in clean energy projects.

John Curtis, U.S. Senator from Utah

Curtis and Bennet lead bipartisan letter affirming U.S. commitments to Taiwan

Senators John Curtis (R-UT) and Michael Bennet (D-CO) led a bipartisan letter urging continued adherence to longstanding U.S.-Taiwan policy ahead of an upcoming summit between President Trump and China’s leader Xi Jinping. The lawmakers emphasized that supporting Taiwan under current laws is vital for regional stability.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Beehive State News.